• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Germany·Consumer Cyclical·MRX.F
Share

Mister Spex SE Stocks

€ 1.09Last Updated 08.10.2026

Issuer Rating

3/7
Performance

Average

Risk

High

Recommendation

Sell

Market Cap

€ 41.52M

€ 1.09
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Mister Spex SE operates as a prominent eyewear retailer throughout various European nations, including Germany, Austria, Finland, France, the Netherlands, Norway, Spain, Sweden, Switzerland, and the United Kingdom. The company's comprehensive product offering includes prescription spectacles, trendy sunglasses, and contact lenses. These items, featuring independent and private labels as well as a selection of premium and luxury brands, are distributed via several channels: its extensive online platforms, dedicated retail stores, and a collaborative network of partner opticians. Mister Spex SE currently oversees around 48 physical "brick and mortar" stores located across Germany, Austria, and Sweden. Founded in 2007, the company's corporate headquarters are situated in Berlin, Germany.

Company Valuation

Undervalued
6/7

Based on key historical and expected multiples, the stock is undervalued relative to its peers. In particular, the stock is of fair value on EV/EBITDA.

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Somewhat favourable
5/7

The average target price of MRX.F is 2.86 and suggests 162% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incr

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

09.10.2026 15:00

TRex Bio IPO: Shares of Eli Lilly's Partner Pharmaceutical Company Are Now Available

09.10.2026 14:39

European telecom stocks plummeted following the U.S. market: SpaceX is entering the mobile carrier market

09.10.2026 13:23

What makes Physical Intelligence—the company Bezos has invested in—so interesting?

09.10.2026 13:07

Three of Freedom's subsidiaries have asked AIX to approve a bond program of up to $1 billion

09.10.2026 12:19

The Uzbek fintech startup Uzum may enter the international debt market

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026